Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - doravirine; lamivudine; tenofovir disoproxil as fumarate - film coated tablets - doravirine 100 mg; lamivudine 300 mg; tenofovir disoproxil as fumarate 245 mg - lamivudine,tenofovir disoproxil and doravirine - delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) is indicated as a complete regimen for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults without past or present evidence of viral resistance to doravirine, lamivudine, or tenofovir.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

janssen pharmaceutica (pty) ltd - capsules - see ingredients - each capsule contains itraconazole 100 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

janssen pharmaceutica (pty) ltd - capsules - see ingredients - each capsule contains itraconazole 100,0 mg

Malta - English - Malta Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - cyclophosphamide - powder for solution for infusion or injection - cyclophosphamide 500 mg - antineoplastic agents

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

msd (pty) ltd - tablet - see ingredients - each tablet contains doravirine 100,0 mg lamivudine 300,0 mg tenofovir disoproxil fumarate 300,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

msd (pty) ltd - tablet - see ingredients - each tablet contains doravirine 100,0 mg

Israel - English - Ministry of Health

megapharm ltd - macimorelin as acetate - granules for suspension - macimorelin as acetate 60 mg - macimorelin - this medicinal product is for diagnostic use only.macimorelin aeterna zentaris is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.

Ireland - English - HPRA (Health Products Regulatory Authority)

athlone pharmaceuticals limited - itraconazole - oral solution - triazole derivatives; itraconazole

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

viatris south africa (pty) ltd - #n/a - not indicated - none

European Union - English - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - breast neoplasms - endocrine therapy - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.